APGE Apogee Therapeutics, Inc.

Fundamentals / CIK 0001974640 / USD

Apogee Therapeutics, Inc. reported $1.34B in total assets and a net loss of $294.4M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open APGE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$0$0$0-$239.2MFY 2022 Net Income: -$39.78M2022FY 2023 Net Income: -$83.98M2023FY 2024 Net Income: -$182.1M2024FY 2025 Net Income: -$255.8M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $214.7M $167.9M $68.42M $27.79M
Total Operating Expenses $285.6M $216.9M $93.00M $30.73M
Operating Income -$285.6M -$216.9M -$93.00M -$30.73M
EBITDA -$284.2M -$216.7M -- --
Interest Income $30.03M $34.74M $9.02M $92K
Income Before Tax -$255.6M -$182.1M -$83.98M --
Income Tax Expense $278K $18K $0 --
Net Income -$255.8M -$182.1M -$83.98M -$39.78M
Basic EPS -$4.22 -$3.30 -$3.36 -$16.16
Diluted EPS -$4.22 -$3.30 -$3.36 -$16.16
Basic Shares Outstanding 60.7M 55.2M 25.0M 2.5M
Diluted Shares Outstanding 60.7M 55.2M 25.0M 2.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Research & Development $67.30M $60.82M $58.44M $54.18M $55.70M $46.39M $60.23M $45.71M
Total Operating Expenses $96.00M $82.77M $78.06M $71.28M $73.17M $63.10M $75.88M $58.69M
Operating Income -$96.00M -$82.77M -$78.06M -$71.28M -$73.17M -$63.10M -$75.88M -$58.69M
EBITDA -$95.60M -$82.36M -$77.65M -$70.88M -$72.77M -$62.89M -$75.81M -$58.64M
Interest Income $11.81M $8.74M $8.73M $6.32M $7.14M $7.84M $8.68M $9.67M
Interest Expense $1.58M -- -- -- -- -- -- --
Income Before Tax -$85.78M -$74.03M -$69.33M -$64.96M -$66.02M -$55.26M -$67.20M -$49.02M
Income Tax Expense $78K $79K $62K $61K $72K $83K $18K $0
Net Income -$85.85M -$74.11M -$69.39M -$65.02M -$66.10M -$55.34M -$67.22M -$49.02M
Basic EPS -$1.14 -$1.06 -- -$1.11 -$1.13 -$0.95 -- -$0.86
Diluted EPS -$1.14 -$1.06 -- -$1.11 -$1.13 -$0.95 -- -$0.86
Basic Shares Outstanding 75.4M 69.7M -- 58.8M 58.4M 58.2M -- 56.8M
Diluted Shares Outstanding 75.4M 69.7M -- 58.8M 58.4M 58.2M -- 56.8M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $131.5M $141.8M $118.3M $151.9M
Short-Term Investments $598.6M $378.9M $277.1M --
Cash & Short-Term Investments $730.2M $520.7M $395.5M $151.9M
Other Current Assets $605K $1.74M $1.21M $57K
Total Current Assets $741.4M $529.7M $398.4M $152.1M
Property, Plant & Equipment, Net $5.69M $1.96M $377K --
Long-Term Investments $172.7M $210.4M -- --
Other Non-Current Assets $8.67M $498K $401K --
Total Non-Current Assets $195.8M $224.2M $3.00M $0
Total Assets $937.1M $754.0M $401.4M $152.1M
Accounts Payable $1.22M $1.07M $2.14M $418K
Total Current Liabilities $27.91M $28.56M $20.56M $9.98M
Total Non-Current Liabilities $5.34M $8.60M $933K $0
Total Liabilities $33.25M $37.16M $21.49M $9.98M
Total Debt (incl. Leases) $8.85M $11.83M $2.00M --
Common Stock $1.0K $1.0K -- --
Retained Earnings -$561.8M -$305.9M -$123.8M -$39.78M
Accumulated Other Comp. Income $1.08M $915K $329K --

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $105.6M $451.8M $131.5M $107.9M $124.2M $106.9M $141.8M $118.8M
Short-Term Investments $866.4M $608.1M $598.6M $419.4M $381.2M $406.4M $378.9M $407.3M
Cash & Short-Term Investments $971.9M $1.06B $730.2M $527.3M $505.4M $513.3M $520.7M $526.0M
Other Current Assets $1.44M $1.18M $605K $919K $963K $586K $1.74M $396K
Total Current Assets $991.7M $1.07B $741.4M $540.1M $516.1M $521.5M $529.7M $534.5M
Property, Plant & Equipment, Net $4.82M $5.28M $5.69M $6.03M $6.44M $5.68M $1.96M $1.42M
Long-Term Investments $321.9M $198.4M $172.7M $61.64M $115.8M $168.1M $210.4M $227.7M
Other Non-Current Assets $10.61M $8.52M $8.67M $8.74M $8.86M $7.34M $498K $514K
Total Non-Current Assets $344.1M $219.9M $195.8M $86.06M $141.7M $192.6M $224.2M $241.8M
Total Assets $1.34B $1.29B $937.1M $626.2M $657.8M $714.2M $754.0M $776.3M
Accounts Payable $3.08M $1.24M $1.22M $376K $5.68M $2.44M $1.07M $2.22M
Total Current Liabilities $37.51M $32.95M $27.91M $34.05M $31.55M $32.96M $28.56M $32.61M
Total Non-Current Liabilities $103.7M $4.91M $5.34M $5.77M $6.82M $7.84M $8.60M $9.27M
Total Liabilities $141.2M $37.86M $33.25M $39.82M $38.37M $40.80M $37.16M $41.88M
Total Debt (incl. Leases) $6.83M $8.05M $8.85M $9.85M $10.85M $11.82M $11.83M $12.14M
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$721.7M -$635.9M -$561.8M -$492.4M -$427.4M -$361.3M -$305.9M -$238.7M
Accumulated Other Comp. Income -$2.50M -$749K $1.08M $1.03M $685K $1.07M $915K $3.27M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$255.8M -$182.1M -$83.98M -$39.78M
Depreciation & Amortization $1.42M $189K -- --
Stock-Based Compensation $46.28M $23.33M $6.10M $2.14M
Change in Payables $150K -$1.07M $1.61M $418K
Operating Cash Flow -$227.4M -$171.2M -$74.76M -$16.43M
Capital Expenditure -$5.15M -$1.15M -$167K --
Free Cash Flow -$232.6M -$172.3M -$74.93M --
Purchases of Investments -$642.3M -$649.5M -$303.7M --
Investing Cash Flow -$179.6M -$300.5M -$273.9M --
Common Stock Issued -- $450.0M $315.4M --
Financing Cash Flow $396.5M $495.1M $315.4M $168.3M
Net Change in Cash -$10.53M $23.47M -$33.28M $151.9M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$85.85M -$74.11M -$69.39M -$65.02M -$66.10M -$55.34M -$67.22M -$49.02M
Depreciation & Amortization $400K $408K $406K $400K $400K $207K $76K $48K
Stock-Based Compensation $16.66M $17.16M $11.93M $11.88M $11.34M $11.13M $7.61M $5.84M
Change in Payables $1.84M $16K $845K -$5.30M $3.23M $1.37M -$1.15M -$3.31M
Operating Cash Flow -$71.38M -$55.57M -$62.69M -$54.26M -$62.03M -$48.48M -$67.71M -$42.52M
Capital Expenditure -- -- -$62K $0 -$768K -$4.32M $1.0K -$751K
Free Cash Flow -- -- -$62.75M -$54.26M -$62.80M -$52.79M -$67.71M -$43.27M
Purchases of Investments -$552.8M -$183.2M -$389.1M -$107.6M -$47.38M -$98.20M -$60.58M -$236.0M
Investing Cash Flow -$381.9M -$35.35M -$288.6M $17.95M $78.12M $12.98M $46.37M -$146.4M
Common Stock Issued -$728K $378.2M -- $0 $0 $0 $0 $0
Financing Cash Flow $107.0M $411.2M $374.9M $19.74M $1.18M $622K $44.36M $383K
Net Change in Cash -$346.2M $320.2M $23.64M -$16.57M $17.28M -$34.87M $23.01M -$188.5M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Return on Assets (ROA) -27.3% -24.2% -20.9% -26.2%
Current Ratio 26.57x 18.55x 19.38x 15.24x
Quick Ratio 26.17x 18.23x 19.24x 15.22x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Return on Assets (ROA) -22.0% -21.2% -27.3% -40.5% -36.1% -28.8% -24.2% -18.9%
Current Ratio 26.44x 32.59x 26.57x 15.86x 16.36x 15.82x 18.55x 16.39x
Quick Ratio 25.91x 32.16x 26.17x 15.49x 16.02x 15.57x 18.23x 16.13x
Source: SEC EDGAR CompanyFacts (CIK 0001974640) · from March 31, 2022 Data through June 30, 2026 · synced Nov 20, 2026, 05:11 UTC · Open in terminal